¬¡¬ä¬à¬á¬Ú¬é¬Ö¬ã¬Ü¬Ú¬Û ¬Õ¬Ö¬â¬Þ¬Ñ¬ä¬Ú¬ä
¬¡¬ä¬à¬á¬Ú¬é¬Ö¬ã¬Ü¬Ú¬Û ¬Õ¬Ö¬â¬Þ¬Ñ¬ä¬Ú¬ä(atopic dermatitis) ¬¥¬Ý¬Ú¬ä¬Ö¬Ý¬î¬ß¬í¬Û ¬ç¬â¬à¬ß¬Ú¬é¬Ö¬ã¬Ü¬Ú¬Û ¬Õ¬Ö¬â¬Þ¬Ñ¬ä¬Ú¬ä, ¬à¬Ò¬í¬é¬ß¬à ¬é¬Ö¬â¬Ö¬Ù 2-3 ¬Þ¬Ö¬ã¬ñ¬è¬Ñ ¬á¬à¬ã¬Ý¬Ö ¬â¬à¬Ø¬Õ¬Ö¬ß¬Ú¬ñ, ¬Ò¬Ñ¬â¬î¬Ö¬â¬ß¬à¬Û ¬æ¬å¬ß¬Ü¬è¬Ú¬Ú ¬Ü¬à¬Ø¬Ú, ¬Ü¬à¬ä¬à¬â¬Ñ¬ñ ¬Õ¬Ö¬Û¬ã¬ä¬Ó¬å¬Ö¬ä ¬Ü¬Ñ¬Ü ¬Ü¬à¬Ø¬ß¬í¬Û ¬Ò¬Ñ¬â¬î¬Ö¬â. ¬¤¬Ö¬ß¬Ö¬ä¬Ú¬é¬Ö¬ã¬Ü¬Ú¬Ö ¬æ¬Ñ¬Ü¬ä¬à¬â¬í, ¬Ú¬Þ¬Þ¬å¬ß¬à¬Ý¬à ¬Ô¬Ú¬é¬Ö¬ã¬Ü¬Ú¬Ö ¬ß¬Ñ¬â¬å¬ê¬Ö¬ß¬Ú¬ñ ¬Ú ¬ß¬Ñ¬â¬å¬ê¬Ö¬ß¬Ú¬ñ ¬ª¬Ù¬Ó¬Ö¬ã¬ä¬ß¬à, ¬é¬ä¬à ¬ß¬Ö¬ã¬Ü¬à¬Ý¬î¬Ü¬à ¬á¬â¬Ú¬é¬Ú¬ß ¬â¬Ñ¬Ò¬à¬ä¬Ñ¬ð¬ä ¬Ó ¬Ü¬à¬Þ¬Ò¬Ú¬ß¬Ñ¬è¬Ú¬Ú.
ExoCobio ¬á¬Ö¬â¬Ó¬í¬Þ ¬Ó ¬Þ¬Ú¬â¬Ö ¬á¬â¬à¬Õ¬Ö¬Þ¬à¬ß¬ã¬ä¬â¬Ú¬â¬à¬Ó¬Ñ¬Ý ¬ï¬æ¬æ¬Ö¬Ü¬ä ¬å¬Ý¬å¬é¬ê¬Ö¬ß¬Ú¬ñ ¬Ñ¬ä¬à¬á¬Ú¬é¬Ö¬ã¬Ü¬à¬Ô¬à ¬Õ¬Ö¬â¬Þ¬Ñ¬ä¬Ú¬ä¬Ñ ¬ã ¬á¬à¬Þ¬à¬ë¬î¬ð ¬ï¬Ü¬Ù¬à¬ã¬à¬Þ.
ExoSCRT ExoSCRT Exosome, ¬Ü¬Ñ¬Ü ¬Ò¬í¬Ý¬à ¬Õ¬à¬Ü¬Ñ¬Ù¬Ñ¬ß¬à, ¬å¬Ý¬å¬é¬ê¬Ñ¬Ö¬ä ¬Ó¬à¬ã¬á¬Ñ¬Ý¬Ö¬ß¬Ú¬Ö, ¬ã¬ß¬Ú¬Þ¬Ñ¬Ö¬ä ¬Ù¬å¬Õ ¬Ú ¬å¬Ü¬â¬Ö¬á¬Ý¬ñ¬Ö¬ä ¬Ü¬à¬Ø¬ß¬í¬Ö ¬Ò¬Ñ¬â¬î¬Ö¬â¬í.
ExoCobio ¬à¬á¬å¬Ò¬Ý¬Ú¬Ü¬à¬Ó¬Ñ¬Ý¬Ñ ¬ã¬ä¬Ñ¬ä¬î¬ð ¬à ¬á¬Ö¬â¬Ó¬à¬Û ¬Ó ¬Þ¬Ú¬â¬Ö ASC-¬ï¬Ü¬Ù¬à¬ã¬à¬Þ¬Ö ¬Õ¬Ý¬ñ ¬å¬Ý¬å¬é¬ê¬Ö¬ß¬Ú¬ñ ¬Ñ¬ä¬à¬á¬Ú¬é¬Ö¬ã¬Ü¬à¬Ô¬à ¬Õ¬Ö¬â¬Þ¬Ñ¬ä¬Ú¬ä¬Ñ. (Cho et al. Stem Cell Research)
ExoSCRT ¬Þ¬à¬Ø¬Ö¬ä ¬å¬Ý¬å¬é¬ê¬Ú¬ä¬î ¬Ñ¬ä¬à¬á¬Ú¬é¬Ö¬ã¬Ü¬Ú¬Û ¬Õ¬Ö¬â¬Þ¬Ñ¬ä¬Ú¬ä ¬Ó ¬Ù¬Ñ¬Ó¬Ú¬ã¬Ú¬Þ¬à¬ã¬ä¬Ú ¬à¬ä ¬Ü¬à¬ß¬è¬Ö¬ß¬ä¬â¬Ñ¬è¬Ú¬Ú ¬ï¬Ü¬Ù¬à¬ã¬à¬Þ¬í.
¬³¬á¬à¬ã¬à¬Ò¬ã¬ä¬Ó¬å¬Ö¬ä ¬Ò¬Ú¬à¬ã¬Ú¬ß¬ä¬Ö¬Ù¬å ¬Ü¬Ö¬â¬Ñ¬Þ¬Ú¬Õ¬à¬Ó, ¬Ü¬Ý¬ð¬é¬Ö¬Ó¬à¬Þ¬å ¬Þ¬Ñ¬ä¬Ö¬â¬Ú¬Ñ¬Ý¬å ¬Õ¬Ý¬ñ ¬Ü¬à¬Ø¬ß¬à¬Ô¬à ¬Ò¬Ñ¬â¬î¬Ö¬â¬Ñ ExoSCRT Exosome
¬²¬Ö¬Ô¬Ö¬ß¬Ö¬â¬Ú¬â¬à¬Ó¬Ñ¬ß¬ß¬í¬Û ¬è¬Ö¬â¬Ñ¬Þ¬Ú¬Õ¬à¬Þ ¬Ü¬à¬Ø¬ß¬í¬Û ¬Ò¬Ñ¬â¬î¬Ö¬â ¬á¬à¬Õ¬Ñ¬Ó¬Ý¬ñ¬Ö¬ä ¬Ó¬ß¬Ö¬ê¬ß¬Ú¬Ö ¬Ó¬à¬ã¬á¬Ñ¬Ý¬Ú¬ä¬Ö¬Ý¬î¬ß¬í¬Ö ¬Ó¬Ö¬ë¬Ö¬ã¬ä¬Ó¬Ñ